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Abstract
Background: Symptoms and signs of leptospirosis are non-specific. Several diagnostic tests for leptospirosis are available
and in some instances are being used prior to treatment of leptospirosis-suspected patients. There is therefore a need to
evaluate the cost-effectiveness of the different treatment strategies in order to avoid misuse of scarce resources and ensure
best possible health outcomes for patients.
Methods: The study population was adult patients, presented with uncomplicated acute febrile illness, without an obvious
focus of infection or malaria or typical dengue infection. We compared the cost and effectiveness of 5 management
strategies: 1) no patients tested or given antibiotic treatment; 2) all patients given empirical doxycycline treatment; patients
given doxycycline when a patient is tested positive for leptospirosis using: 3) lateral flow; 4) MCAT; 5) latex test. The
framework used is a cost-benefit analysis, accounting for all direct medical costs in diagnosing and treating patients
suspected of leptospirosis. Outcomes are measured in length of fever after treatment which is then converted to
productivity losses to capture the full economic costs.
Findings: Empirical doxycycline treatment was the most efficient strategy, being both the least costly alternative and the
one that resulted in the shortest duration of fever. The limited sensitivity of all three diagnostic tests implied that their use
to guide treatment was not cost-effective. The most influential parameter driving these results was the cost of treating
patients with complications for patients who did not receive adequate treatment as a result of incorrect diagnosis or a
strategy of no-antibiotic-treatment.
Conclusions: Clinicians should continue treating suspected cases of leptospirosis on an empirical basis. This conclusion
holds true as long as policy makers are not prioritizing the reduction of use of antibiotics, in which case the use of the latex
test would be the most efficient strategy.
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Introduction
Leptospirosis is a zoonosis of worldwide distribution, caused by
infection with pathogenic spirochetes of the genus Leptospira.
Human leptospirosis is an important health problem in Asia [1–3]
and Latin America [4,5]. The source of infection in humans is
either direct or indirect contact with the urine of an infected
animal, whether livestock, domestic pets, rodents or wild animals.
Veterinarians, abattoir workers and other occupations which
require contact with animals are at risk of infection. Indirect
contact can also cause infection in occupations such as rice field
workers, sewer workers, and soldiers. Peak incidence occurs during
the rainy season in tropical regions. Clinical manifestations of
leptospirosis are non-specific, varying from subclinical infection,
through self-limited anicteric febrile illness with or without
meningitis, to severe and potentially lethal multisystem illness
with jaundice and renal failure [6,7].
Recent findings show that leptospirosis is a common cause of
undifferentiated febrile illness in developing countries [3,8,9].
Early diagnosis of leptospirosis is essential since antibiotic therapy
provides greatest benefit when initiated early in the course of
illness [6,7]. Diagnosis at an early phase, however, is hampered by
the non-specific presentation of leptospirosis. A number of
diagnostic tests for leptospirosis are available, all of these test are
aimed to detect specific antibody against pathogenic Leptospira.
These tests have so far shown low levels of accuracy, questioning
their usefulness in the selection of appropriate antimicrobial
treatment [10]. Nonetheless, these tests are often used in routine
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therefore to determine whether it is cost-effective to perform these
screening tests for leptospirosis in patients with acute febrile illness
suspected of mild leptospirosis, and if so, which diagnostic assay is
most cost-effective, in the outpatient setting.
Methods
The economic framework used in this study is a cost-benefit
analysis, where the direct diagnosis and treatment costs are
compared with productivity gains under the different diagnosis
and treatment strategies. The perspective of the analysis is
therefore a societal one, capturing both provider costs and patient
productivity gains.
While much of the data were collected in a concurrent clinical
study [11], the study population in this analysis was a hypothetical
cohort of adult patients (.14 years) who present with acute fever
(,15 days) suspected of leptospirosis i.e., no obvious focus of
infection, without severe complications or impaired consciousness,
and aresuitable for oralantimicrobial therapy. Malaria and obvious
cases of dengue infection, and pregnant women are excluded.
We compared the cost and outcomes of five management
strategies. Under the first strategy patients were not given
antibiotic treatment; this provides the baseline with which other
strategies are compared in terms of their incremental costs and
outcomes. Under the second strategy all patients were given
empirical treatment consisting of a 7-day course of doxycycline,
100 mg bid treatment. Strategies 3 to 5 consisted of provision of a
7-day course of doxycycline to patients with a positive test result
using either a lateral flow test, a microcapsule agglutination test
(MCAT), or a latex test. Patients with a negative test result were
assumed to receive no antibiotic treatment. Patients given
doxycycline could experience antibiotic side effects such as rash
or gastrointestinal distress. Patients with leptospirosis or rickettsial
infection (scrub typhus or murine typhus) who did not receive an
antibiotic could develop a serious disease complication, such as
renal failure or aseptic meningitis.
The primary measure of effectiveness was the duration of fever
following the hospital visit, which in turn determined the
productivity losses for days off work. The reduction in productivity
losses following either empirical treatment or the use of the
diagnostic tests was compared to the productivity losses of the no-
antibiotic -treatment strategy; these provided the productivity gains
associated with each strategy. For direct medical costs we used
charges, rather than costs. These were applied to the cost of initial
diagnosis and treatment and the subsequent treatment of any
adverse reactions to the drugs and further complications to
patients that did not receive appropriate initial treatment.
The costs and productivity gains for each strategy were then
compared. Where a strategy is both less costly and more effective
than the no-antibiotic-treatment option it clearly dominates. Where
one strategy incurs higher costs and higher benefits than the
baseline (or any other comparator) its efficiency is calculated using
a benefit-cost ratio (BCR), a product of the difference in costs
divided by the difference in outcomes. Where the BCR is above 1
the intervention can be considered cost-effective.
Decision Model
WedevelopedadecisiontreewithMarkovnodes[12]tocompare
the costs and outcomes of a hypothetical cohort of 10,000 patients
with suspected leptospirosis under each of the strategies (Figure 1).
All patients began the simulation with acute fever and symptoms
suggestive of leptospirosis. The model simulated the natural history
of suspected leptospirosis progression over a 7-day period, during
which the patients make various possible transitions; if they are sick,
they may remain sick, become well, become sick with an antibiotic
side effect, or develop a serious disease complication. A 7-day limit
was applied because most patients became afebrile within this
period, as shown in our concurrent clinical study [11]; the
remaining proportion of febrile patients at the end of the 7 day
period was also calculated. The model estimated the number of
fever days associated with each strategy by summing the daily
proportions of patients without fever. Given the short time horizon
of 7 days, costs and outcomes were not discounted.
Assumptions of the model. We made the following
assumptions in structuring the model:
1. Once resolved, symptoms did not recur during the study
period;
Figure 1. The decision model showing each of the treatments
and diagnostic options (first five branches). The square at the far
left of the diagram represents a decision node, with each branch
representing the clinical management choices. The brackets indicate
that patients who received each of the strategies proceeded to the
subtree to the right. The circles at the start of each subsequent
branching indicate chance nodes representing the uncertainty sur-
rounding possible subsequent outcomes indicated in the branches to
the right. This diagram shows the portion of the decision tree modeling
the management strategies, the prevalence of leptospirosis, and
diagnostic test performance (sensitivity and specificity).
doi:10.1371/journal.pntd.0000610.g001
Author Summary
Symptoms and signs of leptospirosis are non-specific. A
number of diagnostic tests for leptospirosis are available.
We compared the cost-benefit of 5 management strate-
gies: 1) no patients tested or given antibiotic treatment; 2)
all patients given empirical doxycycline treatment; patients
given doxycycline when a patient is tested positive for
leptospirosis using: 3) lateral flow; 4) MCAT; 5) latex test.
Outcomes were measured in duration of fever which is
then converted to productivity losses to capture the full
economic costs. Empirical doxycycline treatment was
found to be the most efficient strategy, being both the
least costly alternative and the one that resulted in the
lowest average duration of fever. The significantly higher
relative cost of using a diagnostic test as compared with
presumptive treatment, and the limited sensitivity of all
the diagnostic tests implied that only the latex test could
be considered cost-effective when compared with the no-
antibiotic-treatment option, and that all three tests were
still inferior to empirical treatment.
Diagnosis and Treatment of Suspected Leptospirosis
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the 7-day course. Side effect occurred only once and required
symptomatic treatment, but did not alter the cure rate;
3. Patients with leptospirosis that received treatment could not
develop a severe complication.
Data Summary
Limited information was available for many of the parameters
in the analysis. Where possible, we used the results of our
concurrent clinical study of adult patients with acute undifferen-
tiated febrile illness suspected of leptospiorsis [11. This study was
conducted between July 2003 and January 2005 at 5 hospitals in
Thailand. The results of this study showed that leptospirosis and
rickettsial infection (mainly scrub typhus and murine typhus) had
similar clinical manifestations, and accounted for approximately
50% of the cause of acute undifferentiated fever. This was
supplemented where necessary with further data from the
literature and expert opinion. Tables 1 through 4 list the values
used for the variables in the model, the range of values tested in
the sensitivity analyses, and the data sources.
Diagnostic Tests
Lateral flow (Lepto Tek, BioMerieux, The Netherlands) is a one
step colloidal gold immunoassay. It is based on the binding of
specific IgM antibodies to the broadly reactive heat- extracted
antigen prepared from the non-pathogenic Patoc 1 strain [13].
This test was first tested in south Andaman, India in 2003 [13].
Microcapsule agglutination test (MCAT, Japan Lyophilization Lab.
Tokyo, Japan) is a passive agglutination assay, using microcapsule
particles of a stable synthetic polymer to which surface cell
components of mixture of 6 sonicated Leptospira spp. (serogroup
Australis,Autumnalis,Hebdomadis,Canicola,Icterohaemorrhagia,
and Pyrogenes) are adsorbed [14]. This test was developed and first
tested in Japan and had been used in Thailand since 1997 [15].
Latex agglutination test (National Institute of Health, Ministry of
Public Health of Thailand) is a latex agglutination test to detect
Leptospira-specific antibodies. This test was developed by
National Institute of Health, Ministry of Public Health of Thailand
and has been used in Thailand since 2001 [16].
These three tests are widely used for the diagnosis of leptospirosis
in Thailand. Field evaluations in endemic areas and in a clinical
study in Thailand indicated that their performance was character-
ized by low sensitivities during acute-phase illness [10,11,13]. The
data are shown in table 2. The costs of these tests were similar.
Prevalence
Prevalence estimates of leptospirosis in different settings varied
from 7–36.9% [3,8,9,11]. The prevalence of leptospirosis in our
latest concurrent clinical study was 26% [11], which we used as a
baseline in this study.
Complications
We considered any major organ dysfunction such as acute renal
failure, hypotension, acute respiratory failure [17] associated with
leptospirosis to be a proxy for severe disease. Although mild
leptospirosis could be self-limiting, complications of untreated
leptospirosis occurred between 10–28% [11,18–20]. We used a
baseline estimated of 10%.
Treatment of Suspected Leptospirosis Patients and Their
Outcomes
We used data from our concurrent clinical study [11] and
findings from the literature on treatment options and their
outcomes [21]. Among patients who presented with acute
undifferentiated fever suspected of being leptospirosis, duration
of fever and rate of complications in patients without leptospirosis
or scrub typhus that did not receive doxycycline therapy were
unknown, and were estimated to be similar to patients who had
leptospirosis but did not receive doxycycline.
Results
Clinical Effectiveness Profile
Not providing antibiotic treatment to any patient yielded the
longest average duration of fever of 5.35 days (95%CI 5.32–5.39),
and the worst cure rate, but avoided all antibiotic side effects.
Empirical antibiotic treatment yielded the shortest duration of
fever, averaging 2.24 days (95%CI 2.23–2.25), the highest cure
rate at the end of the first week, and avoided any complications; it
also, however, led to the highest rate of antibiotic side effects
(Table 5). The application of lateral flow, MCAT or latex tests
yielded average durations of fever of 4.66 (95%CI 4.70–4.89), 4.83
(95%CI 4.80–4.87) and 4.30 (95%CI 4.25–4.34), days respective-
ly. Between 5–9% of patients developed complications, dependent
on the exact test sensitivity and specificity.
Costs
The baseline strategy of no-antibiotic- treatment incurred an
average cost of 13.3 USD per patient. With no initial diagnosis or
treatment costs, this expenditure is due entirely to patients that
develop complications, not having received initial treatment.
Empirical treatment of all patients incurred far lower expenditure
Table 1. Values and sources of inputs used in the decision
model.
Input
Base Case
Value, %
Leptospirosis prevalence [11] 26
Antibiotic side effect (rate) [11] 24.3
Complication due to untreated leptospirosis [16–19] 10
Complication due to untreated rickettsial infection 10
Complication due to other undifferentiated untreated illnesses [11] 8.4
doi:10.1371/journal.pntd.0000610.t001
Table 2. Test performance using acute sera [10,14].
Test Base case Sensitivity Analysis Range
(Lower bound) (Upper bound)
Lateral flow test
Sensitivity 0.34 - 0.70
Specificity 0.88 0.83 0.95
MCAT
Sensitivity 0.36 0.26 0.81
Specificity 0.91 0.73 0.95
Latex test
Sensitivity 0.51 0.35 0.74
Specificity 0.73 0.60 0.95
doi:10.1371/journal.pntd.0000610.t002
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USD. This is comprised mostly (74%) of the initial treatment cost,
with the remaining expenditure due to the treatment of side-
effects. The diagnostic tests all incurred similar costs, between15.3
and 17.2 USD. These costs were largely driven by the treatment of
severe complication (approximately 60%), with the tests them-
selves being the second largest component (approximately 35%).
When comparing the costs and productivity gains of the different
strategies,empiricaltreatmentclearlydominatestherest,beingboth
the cheapest and most effective option. When compared to the no-
antibiotic-treatment option, use of all three diagnostic tests provides
someproductivity gains, but alsoincurs higher costs. Accounting for
the differences in costs and productivity, only the latex test had a
BCR above one (2.68), while the BCRs for the lateral flow and
MCAT tests were 0.71 and 0.75, respectively (Table 6).
Sensitivity Analyses
We performed sensitivity analyses to examine the effect of
varying parameter values used in the analysis as specified in tables 2
and 3 and using a leptospirosisprevalence of 10% and 35%; this did
not significantly alter results therefore these are not presented in
detail. With lower or higher prevalence, empirical treatment
remained the least costly and most effective strategy. Increased test
sensitivity and specificity to 95% had little impact on overall costs
and outcomes (Table 5). Increase test accuracy in the high leptos-
pirosisprevalenceareahasmuchmoreimpactwhen compared with
the lower leptospirosis prevalence area, in terms of cost per patient
(14.93 vs. 17.22 USD), duration of fever (4.14 vs. 4.88 days),
percentage of patients with fever at day 7 (4.14% vs. 4.88%) and
percentage of patients with complications (5.8% vs. 7.7%). Varying
the costs of the tests and of doxycycline within a reasonable range
did not alter the results in favor of either of the tests; in fact
doxycycline would have to cost over 29 USD, well beyond its
current price, for the latex test to become a more efficient strategy.
Discussion
Leptospirosis has become an important public health problem
worldwide [22]. Much emphasis has been placed on the
development of improved serologic tests that use whole cell
Leptospira antigen preparations. Commercial whole –based assays
are available in rapid formats amenable for ‘point- of- care’ use.
Field evaluations indicate that these assays are characterized by
low sensitivities (39–72%) during acute – phase illness [10,22].
Lateral flow, MCAT, and latex tests are widely used assays for the
diagnosis of leptospiorsis in Thailand. Because of their relatively
high costs and low sensitivities, use of these tests for the initial
management of acute leptospirosis was inferior to empirical
treatment, and only the latex test was cost-effective when
compared to the no-antibiotic- treatment option.
Empirical treatment with doxycycline was found to be the most
cost-effective strategy, being both cheap and effective in treating
uncomplicated leptospirosis and other causes of febrile illness.
Results from our concurrent clinical study showed that acute
undifferentiated fever, i.e. acute fever without an obvious focus of
infection, is the most common clinical presentation of both
leptospirosis and scrub typhus [11]. Antibiotic treatment with either
doxycycline or azithromycin shortened the duration of fever in both
these and other illnesses. The use of a diagnostic test therefore
implies that where a test provides a negative result, true or false, the
patient would be denied a potentially effective treatment.
Treatment failure occurred in 2% of intended-to- treat patients.
The limitation of doxycycline empirical therapy was nausea/
vomiting which occurred in about 24.3% of doxycycline treated
patients and severe adverse events (rash and severe vomit)
developed in 2 out of 145 treated patients [11].
Other epidemiological studies showed that ‘‘systemic infection’’
such as dengue infection, rickettsial infection, brucellosis, Q fever,
CMV or EBV infection was common causes of acute fever
syndrome, and in many cases fever disappeared without specific
diagnosis being established [23]. Doxycycline was the most common
empirical antimicrobial therapy for this syndrome and all episodes
resolved without further complications. Shorter duration of fever
amongthosepatientswhoreceived treatmentwasalsoobserved [23].
Table 3. Outcome of treatment.
Data Distribution
Base Case
Value, day (SD)
Sensitivity
Analysis Value
In leptospirosis Duration of fever with doxycycline treatment[11,19] Normal 2.04 (1.04) 0.33–4.92
Duration of fever without doxycycline treatment [19] Normal 5.4 (0.3) -
In non-leptospirosis: Rickettsial infection Duration of fever with doxycycline treatment [11] Lognormal 1.62(0.67) 0.5–4.5
In non-leptospirosis: Others Duration of fever with doxycycline treatment [11] Lognormal 2.67 (2.46) 0.33–15.8
Duration of fever without doxycycline treatment [11,18] Normal 5.3 (1.3) -
doi:10.1371/journal.pntd.0000610.t003
Table 4. Costs (USD).
Base Case Value, USD
Doxycycline prescription 2
a
Lateral flow test 5.7
b
MCAT 5.7
b
Latex test 5.7
b
Doxycycline side effect, per day
- no work loss 2.9
c
- work loss 5.25
Disease outcome (at end of 7-day course)
- Cure 0
- Sick (daily cost of work loss from leptospirosis) 5.25
- Serious complication 341
d
aCost of doxycycline (100 mg) 14 capsules in Thailand
bCost as of 2004 of lateral flow, MCAT, latex test.
cTreatment of side effect symptoms such as antiemetic drug or antihistamine
for rash.
With work loss, 1 day at minimum earning (5.25 USD) assumed.
There is no additional cost to patients not receiving antibiotics or to being cured.
dEstimate of hospital costs, including intravenous antibiotics, other treatment.
doi:10.1371/journal.pntd.0000610.t004
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the potential harm to society that results in the overuse of
doxycycline, which could eventually lead to increased bacterial
resistance, reduced future effectiveness, and increased drug costs.
Leptospiral resistance to doxycycline has not been described. More
studies to clarify the link between individual antibiotic use and
emerging community resistance are needed. If policy makers wish
to prioritize the reduction in antibiotic use with the use of a
diagnostic test, this study shows that the use of the latex test can be
considered cost-effective.
The data used in this analysis concerning doxycycline treatment
was determined from our prospective clinical study [11]. The data
used for the no-antibiotic-treatment group on the other hand was
limited by its reliance on published data and expert opinion. The
sensitivity analysis however showed that variation in these
parameters, within reason, did not have a significant impact on
results. Lastly, the costs for direct medical expenses was based on
charges, rather than actual economic costs; based on familiarity
with the Thai healthcare system we assume that actual costs are
higher, therefore the cost-effectiveness of the intervention is likely
to be slightly higher than that found in the analysis.
In summary leptospirosis is a common cause of acute
undifferentiated fever in rural areas where limited resources are
available. Results of this study and other clinical studies [11,23]
show that empirical treatment with doxycycline would be the most
cost-effective option for these patients, as this strategy was also
beneficial for patients with other diseases which clinically mimic
leptospirosis such as scrub typhus. It should be noted that this
strategy applies only to adult patients with acute fever suspected of
mild leptospirosis. Patients with potentially more serious diseases
should be treated more aggressively than implied by this analysis.
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Table 5. Costs, clinical outcomes and antibiotic prescription at various prevalence rates and for patients receiving no treatment,
empirical treatment, diagnosis using the latex test and diagnosis with a test with 95% sensitivity and specificity.
Average cost/
patient (USD) Health outcomes Doxycycline Prescriptions
Duration of fever (Patients
with fever at D7, %)
Patients with
side effect, %
Patients with
complications, %
Patients without
leptospirosis given
doxycycline, %
Patients with
leptospirosis not
given doxycycline, %
10% prevalence
No antibiotic Rx 13.3 5.35 (5.8) 0 9.3 0 100
Empirical Rx 2.7 2.29 (1.7) 24 0 100 0
Latex test 15.7 4.44 (4.6) 7 6.47 27 49
High accuracy test 17.22 4.88 (5.54) 3 7.7 5 5
26% prevalence
No antibiotic Rx 13.3 5.35 (4.7) 0 9.3 0 100
Empirical Rx 2.7 2.24 (1.3) 24 0 100 0
Latex test 15.4 4.30 (3.8) 8 6.2 27 49
High accuracy test 15.75 4.38 (4.53) 7 6.5 5 5
35% prevalence
No antibiotic Rx 13.3 5.35 (4.26) 0 9.3 0 100
Empirical Rx 2.7 2.22 (1.22) 24 0 100 0
Latex test 15.25 4.23 (3.42) 9 6.0 27 49
High accuracy test 14.93 4.14 (4.07) 9 5.8 5 5
doi:10.1371/journal.pntd.0000610.t005
Table 6. Benefit-cost ratios for the different strategies.
Strategy Direct costs (USD) Productivity loss (USD) Benefit-cost ratio
No –antibiotic- treatment 13.26 28.4 (Baseline)
Empirical treatment 2.70 11.8 21.57
*
Latex test 15.41 22.6 2.68
Lateral flow test 17.30 25.5 0.71
MCAT 17.23 25.4 0.75
*The negative value is a result of the empirical treatment strategy being both less expensive and more effective than the no –antibiotic- treatment baseline
doi:10.1371/journal.pntd.0000610.t006
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